BIC/FTC/TAF (bictegravir/emtricitabine/tenofovir alafenamide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIC/FTC/TAF (bictegravir/emtricitabine/tenofovir alafenamide), covering 2025-06-04 to 2025-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Rapid Antiretroviral Treatment Initiation With BIC/FTC/TAF in HIV-infected People Who Inject Drugs (PWID)